Scientific Research on Yoga for Treating Psychiatric Disorders

For thousands of years, yoga has been practiced as a path to inner balance. In the last two decades, however, it has stepped out of ashrams and into psychiatry departments, neuroimaging labs, and randomized controlled trials. Researchers are now asking a sharper question: does yoga actually change the brain and improve mental illness, or is it just gentle stretching with good marketing? The answer, based on a growing body of clinical evidence, is surprisingly substantial.

Why scientists started taking yoga seriously 🔗

Mental illness accounts for a heavy share of the global disease burden, and conventional treatments, while effective, do not work for everyone. Medications can have side effects, therapy is expensive, and access is limited, particularly in low- and middle-income countries. This treatment gap pushed clinicians to look at complementary interventions, and yoga emerged as a strong candidate because of its low cost, minimal side effects, and cultural acceptability.

A systematic review published in Frontiers in Psychiatry examined randomized controlled trials of yoga across neuropsychiatric disorders and found emerging scientific support for yoga in treating depression, sleep problems, and as an adjunct in schizophrenia and ADHD. Around the same time, the National Institute of Mental Health and Neurosciences (NIMHANS) in Bengaluru established a dedicated Integrated Centre for Yoga, signalling that yoga research had moved from the fringe into mainstream psychiatric inquiry.

Yoga and mood: what the depression studies show 🔗

Depression is the most studied psychiatric condition in yoga research, and the findings are consistently encouraging. Trials using protocols built around asana (postures) and pranayama (breath regulation) have shown clinically meaningful reductions in depressive symptoms, both as a standalone intervention in mild to moderate depression and as an add-on to antidepressants in more severe cases.

A review in the British Journal of Psychiatry notes that yoga has been shown to be useful as a monotherapy in mild to moderate depression and as an adjuvant in several psychiatric disorders, including schizophrenia, anxiety disorders, substance use disorders, and mild cognitive impairment. Importantly, these effects are not limited to subjective mood scores; they appear alongside measurable biological changes.

How yoga compares with exercise 🔗

A natural counter-argument is that any physical activity improves mood, so yoga is nothing special. Researchers have tested this directly. A randomized controlled trial conducted at Boston University compared a 12-week yoga programme with a metabolically matched walking programme. Both groups exercised three times a week for 60 minutes. The yoga group showed greater improvements in mood and anxiety than the walking group, suggesting that the mind-body integration in yoga adds something beyond the cardiovascular benefits of plain exercise.

The neurotransmitter story: yoga and GABA 🔗

One of the most exciting threads in this research concerns gamma-aminobutyric acid (GABA), the brain’s primary inhibitory neurotransmitter. GABA acts as a calming brake on neural activity. Low GABA levels are linked with depression, anxiety, and epilepsy, and many psychiatric medications work by boosting GABA activity. If yoga could raise GABA naturally, it would explain a great deal.

In a landmark study, researchers at Boston University School of Medicine used magnetic resonance spectroscopy to measure brain GABA levels before and after a yoga session. They found a 27 per cent increase in GABA levels in experienced yoga practitioners after a single 60-minute session, compared to almost no change in a control group that read quietly for the same duration. This was the first direct neurochemical evidence that yoga changes brain chemistry in a way relevant to mood disorders.

Subsequent work extended these findings to clinical populations. A 12-week Iyengar yoga and coherent breathing intervention in patients with major depressive disorder produced significant increases in thalamic GABA levels alongside reductions in depression scores on the Beck Depression Inventory. The researchers also observed that the GABA boost was time-limited, much like medication, and that maintaining one yoga session per week appeared to sustain elevated GABA levels.

Beyond GABA: the wider neurobiological picture 🔗

GABA is only part of the story. A review of biomarker evidence in yoga and psychiatric disorders identifies several mechanisms through which yoga appears to act on the nervous system. These include modulation of the hypothalamic-pituitary-adrenal (HPA) axis, which governs the body’s stress response, enhancement of GABAergic neurotransmission, autonomic balancing through increased parasympathetic (vagal) tone, and neuroendocrine shifts involving cortisol, oxytocin, and brain-derived neurotrophic factor (BDNF).

This convergence of biological pathways helps explain why yoga has such broad effects: rather than targeting a single neurotransmitter, it nudges multiple systems towards equilibrium at the same time.

Yoga in schizophrenia and other serious mental illness 🔗

Schizophrenia is one of the most disabling psychiatric conditions, and even with modern antipsychotics, many patients continue to struggle with negative symptoms, cognitive deficits, and impaired social functioning. NIMHANS researchers have led several randomized trials testing yoga as an add-on therapy in this population.

In one study, sixty-one moderately ill patients with schizophrenia were randomly assigned to either yoga therapy or physical exercise therapy alongside their usual antipsychotic medication. After four months, the yoga group showed significantly less psychopathology than the physical exercise group, particularly on measures of negative symptoms and social functioning.

A more recent six-month randomized controlled trial involving 110 patients with schizophrenia at NIMHANS and a community mental health centre in Karnataka confirmed and extended these results, showing improvements in symptoms and quality of life with yoga as an add-on intervention. A review in yoga therapy for schizophrenia notes that benefits include reduced psychotic symptoms, lower depression, improved cognition, better quality of life, and neurobiological changes such as increased plasma oxytocin levels, the hormone associated with social bonding.

Anxiety, PTSD, and substance use 🔗

For anxiety disorders, the evidence is also solid. A trial of 226 adults with generalized anxiety disorder compared 12 weeks of Kundalini yoga, cognitive behavioural therapy (CBT), and stress education. The yoga group improved significantly more than the stress education group, although CBT still outperformed yoga, supporting CBT as first-line treatment while establishing yoga as efficacious. Comparable findings exist for post-traumatic stress disorder, eating disorders, and obsessive-compulsive symptoms, although the quality of evidence varies.

Yoga has also been studied as an adjunct in substance use disorders, including opioid use disorder, where it appears to reduce withdrawal symptoms, anxiety, and sleep disturbance by restoring autonomic balance, an area where pharmacological treatment alone often falls short.

Cognitive function and the ageing brain 🔗

Mental health is not only about mood. Cognitive decline in older adults is a growing public health concern, and yoga has shown promise here too. Studies in mild cognitive impairment, often a precursor to dementia, suggest improvements in memory, attention, and executive function with regular yoga practice. The proposed mechanisms include increased cerebral blood flow, reduced systemic inflammation, and elevated BDNF, a protein essential for neuronal growth and plasticity. The evidence-based integration of yoga into psychiatric practice has therefore expanded to include geriatric and childhood disorders such as ADHD and autism spectrum conditions.

The clinical case: why yoga fits Indian mental healthcare 🔗

Beyond efficacy, yoga has practical advantages that matter enormously in resource-limited settings. It is low-cost, requires no special equipment, can be taught in groups, and has minimal adverse effects when delivered by trained instructors. For a country with a severe shortage of psychiatrists and psychologists, a scalable, culturally familiar intervention is invaluable.

The Ministry of AYUSH has supported yoga research collaborations with NIMHANS and other institutions, helping develop standardized, condition-specific yoga modules for depression, schizophrenia, and anxiety. These manualized protocols address one of the long-standing criticisms of yoga research, namely the lack of consistency in what is actually being delivered.

The limitations to keep in mind 🔗

None of this means yoga is a replacement for psychiatric care. Most rigorous reviews emphasize that the existing evidence, while promising, is of moderate quality and needs replication in larger, multi-centre, blinded trials. Blinding is genuinely hard with a physical intervention, and finding a true placebo for yoga is almost impossible. Severe psychiatric conditions like acute psychosis or suicidal depression require medication, hospitalization, and professional supervision. Yoga is best understood as a complementary therapy that enhances, not replaces, established treatment.

There are also barriers on the ground. A NIMHANS study examining why patients with schizophrenia declined yoga therapy found that over half of eligible patients refused participation, citing distance, lack of family support, work commitments, and scepticism. Translating clinical efficacy into real-world impact will require thoughtful integration into community mental health systems.

Where the science is headed 🔗

The next wave of research is using functional MRI, PET imaging, genomics, and inflammatory marker panels to map exactly how yoga changes the brain and body. Studies on the complement pathway in major depressive disorder have shown that long-term add-on yoga therapy can modulate immune-inflammatory processes, linking yoga to the broader story of inflammation in mental illness. As biomarker research matures, yoga is likely to move from a general wellness recommendation to a targeted prescription matched to specific conditions and patient profiles.

What do you think? If yoga can measurably change brain chemistry and improve symptoms in serious conditions like schizophrenia and depression, should it be a standard part of mental healthcare in India rather than an optional add-on? And what would it take to bring evidence-based yoga therapy to the patients who need it most, especially in rural and underserved communities?

References

1. https://www.frontiersin.org/journals/psychiatry/articles/10.3389/fpsyt.2012.00117/full
2. https://www.cambridge.org/core/journals/the-british-journal-of-psychiatry/article/yoga-for-psychiatric-disorders-from-fad-to-evidencebased-intervention/0C48FB07C5D3CA0D1E2DF896131567A2
3. https://pmc.ncbi.nlm.nih.gov/articles/PMC3111147/
4. https://www.sciencedaily.com/releases/2007/05/070521145516.htm
5. https://www.bumc.bu.edu/camed/2020/02/03/researchers-identify-link-between-decreased-depressive-symptoms-yoga-and-the-neurotransmitter-gaba/
6. https://pubmed.ncbi.nlm.nih.gov/31727200/
7. https://onlinelibrary.wiley.com/doi/10.1111/j.1600-0447.2007.01032.x
8. https://pubmed.ncbi.nlm.nih.gov/38795661/
9. https://pmc.ncbi.nlm.nih.gov/articles/PMC3410202/
10. https://www.mdpi.com/2673-5318/2/4/30
11. https://pmc.ncbi.nlm.nih.gov/articles/PMC9983454/
12. https://pmc.ncbi.nlm.nih.gov/articles/PMC3555015/
13. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3276937/
14. https://www.sciencedirect.com/science/article/abs/pii/S1876201821003324